Scientific publications

Non-Compromised Efficacy of the First Commercial Ready-to-Use Genotype 2d Porcine Circovirus Type 2 and Mycoplasma hyopneumoniae Vaccine

Nimród Pálmai, Nikoletta-Ágnes Széplaki, Bálint Molnár, Han Smits, Roman Krejci and István Kiss

Non-Compromised-Effi (4.36 MB)Download

Efficacy of a Novel PCV2d and Mycoplasma hyopneumoniae Combined Vaccine in Piglets with High and Low Levels of PCV2 Maternally Derived Antibodies at Vaccination

Mònica Sagrera, Laura Garza-Moreno, Àlex Cobos, Anna Maria Llorens, Eva Huerta, Mónica Pérez, Diego Pérez, David Espigares, Joaquim Segalés and Marina Sibila

Eﬃcacy-of-a-Novel- (7.63 MB)Download

Efficacy of a new ready-to-use PCV2 and Mycoplasma hyopneumoniae vaccine under field conditions

Peter Trampus, Attila Csagola, Tamas Szalai, Nimrod Palmai, Adam Toth, Nora Terenyi, Zoltan Nagy, Nikoletta-Agnes Szeplaki, Gergely Somogyi, Eniko Rausch, Zoltan Penzes, Roman Krejci

Efficacy-of-a-new-re (365.51 KB)Download

Reproductive efficacy of a modified-live porcine reproductive and respiratory syndrome vaccine against Korean PRRSV-2 challenge in sows

Jeongmin Suh, Tae-Eun Kim, Sehyeong Ham, Hyejin Na, Ikjae Kang, Sang-Ho Cha , Sun Hee Cho and Chanhee Chae

Persoporc-sow-2026-S (930.21 KB)Download

Virus Attenuation by Genome-Scale Changes in Codon Pair Bias

J. Robert Coleman, Dimitris Papamichail, Steven Skiena, Bruce Futcher, Eckard Wimmer, and Steffen Mueller

Pre-Persoporc-2008-C (500.32 KB)Download

Intradermal co-inoculation of codon pair deoptimization (CPD)-attenuated chimeric porcine reproductive and respiratory syndrome virus (PRRSV) with Toll like receptor (TLR) agonists enhanced the protective effects in pigs against heterologous challenge

Changhoon Park, Myung-Shin Lee, Jong Hyuk Baek, Sun Hee Cho, Bang-Hun Hyun, Su-Hwa You, Sang-Ho Cha

Pre-Persoporc-2021-P (2.66 MB)Download

Controlled, blinded and randomised field efficacy, and return-on-investment study of a next-generation porcine reproductive and respiratory syndrome virus type 2 (PRRSV2) modified live virus (MLV) vaccine

Preben Mortensen, Nicolas Guerra, Han Smits

IMM-CP-02-ESPHM25-Pe (1.48 MB)Download

A next-generation PRRSV-2 MLV vaccine in a controlled comparative field trial in an industrial swine system in Cambodia

Xuan Van Doan, Kriangsak Laosakul, Philip Chhran, Sarim Seng, Sovanna Kem

P1-028-A-APVS25-Pers (203.32 KB)Download

Parallel, randomised field efficacy, and return-on-investment study of a next-generation PRRSV2-MLV vaccine compared to a conventional lineage 7 based PRRSV2-MLV vaccine

Thongchai Amonrattanaporn, Naritsara Boonraungrod, Nongnapas Ruangpet, Kathrin Lillie-Jaschniski, Preben Mortensen

VVD-PO0074-IPVS2026- (7.10 MB)Download

Parallel, randomised field efficacy, and return-on-investment study of a next-generation PRRSV2-MLV vaccine compared to a conventional PRRSV1-MLV vaccine in a PRRSV1+2 endemic herd

Naritsara Boonraungrod, Thongchai Amonrattanaporn, Worrapon Prucksayoungyuen, Kathrin Lillie-Jaschniski, Preben Mortensen

VVD-PO0490-IPVS2026- (7.87 MB)Download